Call Us Today at 508-231-8842        EMERGENCY

Ashland, MA: MEDIcept Inc, a leading international quality and regulatory consulting firm focused on medical device and in-vitro diagnostics (IVD), and Reilly & Associates, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies.

The merger promotes the shared strategic goal of becoming a world-wide, leading quality and regulatory value-added service firm focusing on medical devices and medical technology. Together the joint firm offers the opportunity to more effectively serve their customers, ranging from start-up, virtual medical device manufacturers to Fortune 500 firms.

Both MEDIcept and Reilly & Associates share a common goal to positively impact medical device compliance and safety. This acquisition provides us with an opportunity to provide medical device manufacturers with value added services as they introduce devices into new markets.

According to F. David Rothkopf, President of MEDIcept, “Both MEDIcept and Reilly & Associates have common core values. We both aim to help start-up and pre-revenue medical device companies navigate the quality and regulatory environment, while assisting large multi-national device manufactures with efficient, tailored auditing and remediation advice.”

“Reilly & Associates is excited to become part of the MEDIcept team,” said Susan Reilly, President of Reilly & Associates, LLC. “This merger provides our ever growing client-base with an extensive network of experienced consultants to serve all of their quality and regulatory needs. As Reilly & Associates and MEDIcept have partnered in numerous projects in the past, the transitions to a single firm will be a simple one for all of our customers.”

We are committed to helping you find the most cost-effective method for achieving our client’s quality goals and regulatory compliance. Our role is determined entirely by your needs, and our objective is to dispense efficient and innovative solutions and assistance.

About MEDIcept:

MEDIcept is a vertically integrated medical device quality assurance, regulatory consulting, and contract testing firm owned and managed by medical industry professionals with direct experience managing medical device development, operations, quality and regulatory activities.

About Reilly & Associates:

Reilly & Associates, LLC is committed to helping you find the most cost-effective method for achieving quality goals and regulatory compliance.  Our role is determined entirely by your needs, and our objective is to dispense efficient and innovative solutions and assistance.

Sign up to receive our Newsletters!

The Latest News

Quality Systems in Motion, Inc. (QSIM) is now part of MEDIcept Inc.

For Immediate Release Ashland, MA: MEDIcept Inc, an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), and QSIM, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies. QSIM, under the direction of Brian Markham, President, specialized in providing leadership and resources for organizations undergoing significant quality system change due to...

Medical Device Risk Management: An ISO14971 Update

In 2000, the first edition of ISO 14971 was released as the international standard for risk management of medical devices. This year, the ISO technical committee (ISO/TC 210) has been hard at work updating this globally-recognized standard. And while the fundamental stages of the risk management process remain unchanged, there are some key modifications that medical device manufacturers should be aware of to ensure that they can successfully navigate the development, testing, and launching of...

Europe’s New Medical Devices Regulation: Ready or Not, Here It Comes

For the past 30 years, the European Union’s medical device market has been regulated by the Medical Devices Directive (MDD). The rapid development of hybrid technologies, tensions between EU member states, and highly bureaucratic procedures for resolving disputes made the text of the Medical Devices Directives seem obsolete much earlier than anticipated. As a result, the European Commission authorized the development of a new set of industry requirements known as the Medical Devices Regulation...